149 related articles for article (PubMed ID: 38287511)
141. The open reading frame L2 of cottontail rabbit papillomavirus contains antibody-inducing neutralizing epitopes.
Christensen ND; Kreider JW; Kan NC; DiAngelo SL
Virology; 1991 Apr; 181(2):572-9. PubMed ID: 1707567
[TBL] [Abstract][Full Text] [Related]
142. Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus.
Lin YL; Borenstein LA; Selvakumar R; Ahmed R; Wettstein FO
Virology; 1992 Apr; 187(2):612-9. PubMed ID: 1312271
[TBL] [Abstract][Full Text] [Related]
143. An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.
Bikorimana JP; Abusarah J; Gonçalves M; Farah R; Saad W; Talbot S; Stanga D; Beaudoin S; Plouffe S; Rafei M
Cancer Sci; 2024 Apr; 115(4):1102-1113. PubMed ID: 38287511
[TBL] [Abstract][Full Text] [Related]
144. The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.
Garbuglia AR; Lapa D; Sias C; Capobianchi MR; Del Porto P
Front Immunol; 2020; 11():188. PubMed ID: 32133000
[TBL] [Abstract][Full Text] [Related]
145. Genetically modified cellular vaccines for therapy of human papilloma virus type 16 (HPV 16)-associated tumours.
Bubenik J
Curr Cancer Drug Targets; 2008 May; 8(3):180-6. PubMed ID: 18473731
[TBL] [Abstract][Full Text] [Related]
146. DNA vaccines for cervical cancer: from bench to bedside.
Hung CF; Monie A; Alvarez RD; Wu TC
Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
[TBL] [Abstract][Full Text] [Related]
147.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
148.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
149.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
